
In a study of 478 resistant hypertension (RH) patients, diagnosing and treating obstructive sleep apnoea (OSA) led to significant short-term reductions in blood pressure (BP), particularly at night. Over a median follow-up of 3 years, these benefits persisted in patients with severe OSA but diminished in those with moderate OSA. Clinical factors like uncontrolled BP, sex, and age predicted BP response to OSA treatment at 1 year.
Like
Save
Share